The US military has approved UK-based MedTrade's Celox gauze bandage, designed to stop severe arterial bleeding in three minutes and save soldiers' lives on the battlefield.
The Committee on Tactical Combat Casualty Care (CoTCCC) has added Celox gauze to its guidelines for control of haemorrhage as approved haemostatic agents for military-wide use.
Five haemostatic gauzes including Celox gauze were compared in a test of severe arterial haemorrhage conducted by the US Navy. In the test Celox Gauze demonstrated higher rates of survival than competing products.
Celox gauze contains a novel technology that allows it to work on the most severe bleeding where current treatments are not effective.
It looks similar to a simple gauze bandage but has been coated with Celox Granules to give unique properties.
In many of the worst injuries, the blood lost causes the body's natural clotting abilities to fail, but Celox acts independently of the blood's clotting mechanism and continues to work even in this situation, where other treatments that use the blood's natural mechanisms may fail.
The treatment is also fully US Food and Drug Administration (FDA) cleared and has been in use with British and other ISAF troops for some time, with consistent results.
A typical case study from the Dutch military medical unit demonstrated the usage of Celox gauze bandage to save lives on the battlefield. Celox has been tested on the battlefield in Afghanistan, where it was used to treat gunshot wounds to an arm, leg and buttock.
Celox gauze was used successfully to control bleeding from the buttock wound, which was more persistent. The bandage was packed in to the wound and helped stop the bleeding.
After Celox gauze was used there was no leakage or re-bleeding when it was removed 24 hours later.
MedTrade Chris Marsden said Celox works alongside other innovations from the conflicts in Iraq and Afghanistan, such as the new tourniquets and drugs that help keep blood clots intact.
"It stops bleeding with simple pressure and is suitably rugged for frontline use," Marsden said. "We're delighted with this review by the CoTCCC and to be able to make a difference in this area."
The US military review follows a recent trend where increasing numbers of civilian emergency services are reviewing their equipment and taking on new treatments.
In a large part, this is in response to tragedies such as the Boston Marathon bombing, as well as new guidelines for responses to indiscriminate shootings.
For example, in the Massachusetts area around Boston the regional council for Homeland Security has prescribed new haemorrhage control kits that include the Celox bandages for their responders.
Image: US military approves new treatment for troops to save lives on the battlefield. Photo: courtesy of MedTrade Products Limited/PR Newswire.